These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Dopamine transporter imaging in autopsy-confirmed Parkinson's disease and multiple system atrophy. Perju-Dumbrava LD; Kovacs GG; Pirker S; Jellinger K; Hoffmann M; Asenbaum S; Pirker W Mov Disord; 2012 Jan; 27(1):65-71. PubMed ID: 22102521 [TBL] [Abstract][Full Text] [Related]
10. Individual time course of pre- and postsynaptic PET imaging may improve differential diagnosis of Parkinson's disease and multiple system atrophy: a case report. Ishibashi K; Nishina H; Ishiwata K; Ishii K BMC Res Notes; 2015 Sep; 8():496. PubMed ID: 26419749 [TBL] [Abstract][Full Text] [Related]
11. α-Synuclein and tau concentrations in cerebrospinal fluid of patients presenting with parkinsonism: a cohort study. Mollenhauer B; Locascio JJ; Schulz-Schaeffer W; Sixel-Döring F; Trenkwalder C; Schlossmacher MG Lancet Neurol; 2011 Mar; 10(3):230-40. PubMed ID: 21317042 [TBL] [Abstract][Full Text] [Related]
12. Diagnostic Potential of Multimodal MRI Markers in Atypical Parkinsonian Disorders. Seki M; Seppi K; Mueller C; Potrusil T; Goebel G; Reiter E; Nocker M; Kremser C; Wildauer M; Schocke M; Gizewski ER; Wenning GK; Poewe W; Scherfler C J Parkinsons Dis; 2019; 9(4):681-691. PubMed ID: 31450511 [TBL] [Abstract][Full Text] [Related]
14. Phosphorylated α-synuclein in skin nerve fibres differentiates Parkinson's disease from multiple system atrophy. Zange L; Noack C; Hahn K; Stenzel W; Lipp A Brain; 2015 Aug; 138(Pt 8):2310-21. PubMed ID: 26017579 [TBL] [Abstract][Full Text] [Related]
15. The value of brain perfusion SPECT for differentiation between mildly symptomatic idiopathic Parkinson's disease and the Parkinson variant of multiple system atrophy. Song IU; Yoo I; Chung YA; Jeong J Nucl Med Commun; 2015 Oct; 36(10):1049-54. PubMed ID: 26087241 [TBL] [Abstract][Full Text] [Related]
16. A totally data-driven whole-brain multimodal pipeline for the discrimination of Parkinson's disease, multiple system atrophy and healthy control. Nemmi F; Pavy-Le Traon A; Phillips OR; Galitzky M; Meissner WG; Rascol O; Péran P Neuroimage Clin; 2019; 23():101858. PubMed ID: 31128523 [TBL] [Abstract][Full Text] [Related]
17. Discriminating α-synuclein strains in Parkinson's disease and multiple system atrophy. Shahnawaz M; Mukherjee A; Pritzkow S; Mendez N; Rabadia P; Liu X; Hu B; Schmeichel A; Singer W; Wu G; Tsai AL; Shirani H; Nilsson KPR; Low PA; Soto C Nature; 2020 Feb; 578(7794):273-277. PubMed ID: 32025029 [TBL] [Abstract][Full Text] [Related]
18. Metaiodobenzylguanidine (MIBG) scintigraphy at various parts of the body in Parkinson's disease and multiple system atrophy. Matsui H; Udaka F; Oda M; Kubori T; Nishinaka K; Kameyama M Auton Neurosci; 2005 Apr; 119(1):56-60. PubMed ID: 15893708 [TBL] [Abstract][Full Text] [Related]